Participated · Series A · Jun 2026

Tombot develops lifelike, fully autonomous robotic companion animals designed to provide comfort and emotional support for older adults and individuals with dementia, anxiety, autism, PTSD, or loneliness. Its flagship product, Jennie, mimics the movements and responses of an 8–10 week-old puppy and has attracted more than 23,000 pre-order and waitlist customers. Jennie first emerged in the marketplace in early 2024 and has generated interest from consumers, healthcare providers, senior living organizations, and caregiving communities. The company is based in Santa Clarita, California, and is preparing for a planned Fall 2026 customer launch. Tombot recently raised $7 million in a Series A3 round to scale manufacturing, expand operations, accelerate commercialization, and expand its companion robotics product line.

Led · Seed · Apr 2026

TrialClinIQ develops an AI-driven platform to support clinical trial recruitment by matching trial protocols to real-world clinical and demographic data. The company is led by founder and CEO Jontel Pierce and is based in Houston, Texas. TrialClinIQ recently closed a $150K Pre-Seed round and has opened a $1.5M funding round to accelerate growth. It was selected for the Caduceus LAUNCH digital health accelerator. The company plans to use the Pre-Seed proceeds to expand operations and advance product development. No operational metrics or revenue figures were disclosed in the report.

Led · Seed · Jun 2025

VoiceCare AI builds agentic, voice-based AI to automate long, complex back-office healthcare workflows and reduce administrative burden. Its flagship voice AI agent, Joy, has been deployed across payer communication processes including benefits verification, prior authorizations, and claims management. The platform is HIPAA-compliant and SOC 2 Type II attested, and includes a proprietary Evaluation Framework (VC-Eval) and a simulation engine to validate accuracy and stress-test performance. VoiceCare emphasizes a "zero-skip, hallucination-free" architecture designed to prevent omitted or misrouted communications and ensure context-bound, verifiable responses. The company emerged from stealth earlier this year and plans to scale operations, enhance platform intelligence, accelerate product development, and expand engineering and go-to-market teams. VoiceCare AI has raised $4.54 million in seed funding to support those efforts. VoiceCare AI offers an agentic, multimodal voice AI platform—branded as "Joy"—designed to automate long, complex healthcare back-office conversations such as benefits verification, prior authorizations, and claims follow-ups. The system uses reinforcement learning from human feedback (RLHF) and proprietary conversational data and is HIPAA compliant and SOC 2 Type II attested. The company says its platform achieves a near-perfect call completion accuracy rate with a majority of calls completed autonomously, and provides detailed documentation and near real-time status updates to integrate with existing workflows. VoiceCare positions its product as a solution to large administrative burdens in U.S. healthcare (citing McKinsey estimates that administration accounts for $1 trillion of spend and that administrators spend 60–80% of time on insurance- and billing-related tasks). The team has assembled an advisory board with healthcare and AI expertise and is running a pilot with Mayo Clinic across neurology, pediatrics, and medical/administrative support operations. Funding will be used to expand the team, boost sales and marketing, and further invest in platform accuracy, security, and compliance.

Led · Equity · May 2025

Reperio Health offers at-home and onsite comprehensive health screenings that deliver instant results via a mobile app paired with FDA-cleared, Bluetooth-connected medical devices. Its ReperioCare experience couples on-demand, AI-assisted analysis with a real-time virtual clinician consultation immediately after screening, enabling personalized insights without long lab delays. The company reports clients have seen screening participation rise by more than 200%, a 95% customer satisfaction rate, near-perfect renewal rates, and thousands of screenings across 40 launches during 18 months of commercialization. The less-than-30-minute tests return instant metrics for blood pressure, heart rate, BMI/relative fat mass, blood glucose, total/HDL/LDL cholesterol, and triglycerides. Reperio says its built-in AI assistant analyzes data, provides insights and follow-up recommendations, and reduces strain on providers. The company plans to expand its AI-assisted, real-time virtual care feature nationwide and grow partnerships with employers and health plans. Reperio Health offers a patent-pending at-home health assessment kit paired with a HIPAA-compliant mobile app that walks users through biometric screenings and delivers immediate, consumer-friendly results. The system uses FDA-approved sensors to perform a blood test measuring total cholesterol, HDL, LDL, triglycerides and glucose, and also captures blood pressure, resting heart rate, BMI and Relative Fat Mass. The app begins with a wellness screening to capture lifestyle patterns and guides users through testing with voiceovers, animations and videos. Reperio plans to accelerate growth and expand proactive health monitoring into the employer market, and to make its assessments available to health plans, retirement facilities, fitness and nutrition practitioners, and directly to individuals. The company completed an oversubscribed $6 million seed capital raise to support those expansion plans. Reperio is based in Portland, Ore., and is led by co-founder and CEO Travis Rush and co-founder/CTO Matt Wallington.

Led · Series A · Jan 2023

UptimeHealth’s software platform lets healthcare administrators and operators manage compliance tasks, predict equipment repair and replacement needs, and tap into a large network of qualified biomed technicians. The product is positioned to support the shift of healthcare delivery away from hospitals and toward outpatient and home settings. The company emphasizes automation and predictive analytics to increase operational efficiency and improve device uptime. UptimeHealth is headquartered in Boston. It announced a $4.5 million Series A to fund growth and expansion in the healthcare services market. Management says the capital will help the company serve more clients in 2023 and scale operations.